Previous 10 | Next 10 |
MOUNTAIN VIEW, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 3, 2021. First Quarter Highlights Closed strategic collaboration with Topcon Corporation netting $19.5 million in new fu...
MOUNTAIN VIEW, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the first qua...
Iridex Corporation (IRIX) Q4 2020 Results Conference Call March 22, 2021 5:00 PM ET Company Participants Leigh Salvo - IR David Bruce - CEO Fuad Ahmad - Interim CFO Conference Call Participants Jonathan Block - Stifel Presentation Operator Ladies and gentlemen, thank you for standing by, and ...
MOUNTAIN VIEW, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that it has completed the previously announced transaction with T...
MOUNTAIN VIEW, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the fourth qu...
Iridex (IRIX) soars 16% premarket after collaborating with Topcon, a Japanese-based manufacturer and distributor. Under the terms agreement, Topcon will acquire exclusive distribution of Iridex laser systems, delivery devices and disposable probes to be sold in Asia Pacific and key ...
Ovid Therapeutics (OVID) +73% after soticlestat deal with Takeda.KemPharm (KMPH) +69% on FDA approval of ADHD drug.Ocugen, Inc. (OCGN) +39% on Indian partner’s COVID-19 vaccine efficacy data.Asensus Surgical (TRXC) +33% on FDA clearance for Senhance Surgical System....
Transaction provides $19.5 million cash to Iridex, as two leaders join forces in glaucoma and retinal disease treatment Iridex to host a conference call presentation on March 2, 2021 at 2:00 p.m. PT/5:00 p.m. ET MOUNTAIN VIEW, Calif., March 02, 2021 (GLOBE NEWSWIRE) ...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning. on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks finished lower Friday, as optimism over President-elect Biden's proposed $1.9 trillion stimulus plan gave way to questions around bip...
Volt Information Sciences VOLT -17% erasing yesterday's gains post Q4 results.Live Ventures LIVE -12% erasing yesterday's gains post FY results.Takung Art (TKAT) -11%.Nano Dimension NNDM -10% after prices $332.5M direct offering.Viveve Medical (VIVE) -1...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company...